Literature DB >> 6160586

Metabolism of native and of lactosylated human low density lipoprotein: evidence for two pathways for catabolism of exogenous proteins in rat hepatocytes.

A D Attie, R C Pittman, D Steinberg.   

Abstract

Human low density lipoprotein (LDL) covalently conjugated with 200-250 residues of lactose per LDL particle (Lac-LDL) was bound and rapidly taken up by the galactose-specific receptor of rat hepatocytes. Uptake of Lac-LDL was associated with inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase and stimulation of cholesterol esterification. Uptake of native human LDL had no significant effects on these enzyme activities even when the rates of LDL uptake equaled those of Lac-LDL. When injected into rats, Lac-LDL was selectively removed by the liver (98% of injected dose). The hepatic subcellular distribution of simultaneously injected native 125I-labeled LDL and 131I-labeled Lac-LDL differed significantly, Lac-LDL was associated with fractions enriched in lysosomal hydrolases whereas native LDL was found predominantly in the supernatant fraction enriched in lactate dehydrogenase. Chloroquine (0.1 mM) markedly suppressed uptake of Lac-LDL by cultured rat hepatocytes (> 80%) but had only a small effect on uptake of native LDL. Leupeptin (0.625 mM) inhibited degradation of Lac-LDL more than it did degradation of native LDL. Colchicine (0.25 microM) dramatically suppressed uptake of Lac-LDL (> 70%) but did not affect native LDL uptake even at concentrations as high as 10 microM. Uptake of human LDL by rat hepatocytes occurs largely by nonspecific mechanisms, including fluid endocytosis, whereas Lac-LDL, as shown here, is taken up by a specific receptor-mediated mechanism. The results show further that native human LDL, representing an example of a protein taken up nonspecifically, is processed intracellularly by a pathway qualitatively distinct from that for Lac-LDL, an example of a protein taken up by a specific mechanism. Lac-LDL may serve as a vehicle for specifically delivering drugs, hormones, or radioactive compounds to hepatocytes for therapeutic or diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160586      PMCID: PMC350184          DOI: 10.1073/pnas.77.10.5923

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  [Methylglutaconase, a new hydrase participating in the metabolism of various carboxylic acids].

Authors:  H HILZ; J KNAPPE; E RINGELMANN; F LYNEN
Journal:  Biochem Z       Date:  1958

2.  Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol.

Authors:  P T Kovanen; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

3.  Turnover and tissue distribution of 125-I-labeled low density lipoprotein in swine and dogs.

Authors:  A D Sniderman; T E Carew; D Steinberg
Journal:  J Lipid Res       Date:  1975-07       Impact factor: 5.922

4.  Replacement of endogenous cholesteryl esters of low density lipoprotein with exogenous cholesteryl linoleate. Reconstitution of a biologically active lipoprotein particle.

Authors:  M Krieger; M S Brown; J R Faust; J L Goldstein
Journal:  J Biol Chem       Date:  1978-06-25       Impact factor: 5.157

5.  Role of microtubules in low density lipoprotein processing by cultured cells.

Authors:  R E Ostlund; B Pfleger; G Schonfeld
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

Review 6.  Endocytosis.

Authors:  S C Silverstein; R M Steinman; Z A Cohn
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

7.  Coordinate secretion of acid hydrolases in rat bile.

Authors:  N F LaRusso; S Fowler
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

8.  Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol.

Authors:  Y S Chao; E E Windler; G C Chen; R J Havel
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

9.  Glycoprotein catabolism in rat liver: Lysosomal digestion of iodinated asialo-fetuin.

Authors:  J H LaBadie; K P Chapman; N N Aronson
Journal:  Biochem J       Date:  1975-11       Impact factor: 3.857

10.  Radiolabeled sucrose covalently linked to protein. A device for quantifying degradation of plasma proteins catabolized by lysosomal mechanisms.

Authors:  R C Pittman; S R Green; A D Attie; D Steinberg
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

View more
  12 in total

Review 1.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

2.  The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants.

Authors:  E Windler; J Greeve; B Levkau; V Kolb-Bachofen; W Daerr; H Greten
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

3.  Chylomicron remnant and asialoglycoprotein metabolism are independent.

Authors:  A D Cooper; D Coleman
Journal:  Lipids       Date:  1985-10       Impact factor: 1.880

Review 4.  GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.

Authors:  Aaron D Springer; Steven F Dowdy
Journal:  Nucleic Acid Ther       Date:  2018-05-24       Impact factor: 5.486

5.  The role of the LDL receptor in apolipoprotein B secretion.

Authors:  J Twisk; D L Gillian-Daniel; A Tebon; L Wang; P H Barrett; A D Attie
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Asialoglycoprotein receptor mediates the toxic effects of an asialofetuin-diphtheria toxin fragment A conjugate on cultured rat hepatocytes.

Authors:  D B Cawley; D L Simpson; H R Herschman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

7.  A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo.

Authors:  R C Pittman; T E Carew; C K Glass; S R Green; C A Taylor; A D Attie
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

8.  Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver.

Authors:  M K Bijsterbosch; T J Van Berkel
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

9.  Site-specific delivery of oligonucleotides to hepatocytes after systemic administration.

Authors:  Lin Zhu; Zhaoyang Ye; Kun Cheng; Duane D Miller; Ram I Mahato
Journal:  Bioconjug Chem       Date:  2007-09-13       Impact factor: 4.774

10.  Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels.

Authors:  L Masucci-Magoulas; A Plump; X C Jiang; A Walsh; J L Breslow; A R Tall
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.